Researchers have taken a step closer to developing a vaccine for a common childhood disease thanks to an atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody. The findings, by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, define the vulnerable shape of a critical RSV component called the fusion glycoprotein./span/spanbr /The NIAID scientists ...
via Medindia Health News
More READ
No comments:
Post a Comment